83 related articles for article (PubMed ID: 7279998)
1. Quantitative structure-reactivity and structure-toxicity relationships of reactivators of phosphylated acetylcholinesterase.
Mager PP
Pharmazie; 1981 Jun; 36(6):450-1. PubMed ID: 7279998
[No Abstract] [Full Text] [Related]
2. Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 3.
Mager PP
Pharmazie; 1982 Nov; 37(11):800-1. PubMed ID: 7163364
[No Abstract] [Full Text] [Related]
3. Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 2.
Mager PP; Das Gupta S
Pharmazie; 1982 Aug; 37(8):607-8. PubMed ID: 7146070
[No Abstract] [Full Text] [Related]
4. Potential acetylcholinesterase reactivators: oxime and amidoxime derivatives.
Serafin B; Majewski M; Kleinrok Z; Jagiełło-Wojtowicz E; Rajtar G; Sieklucka-Dziuba M; Kolasa K
Arch Immunol Ther Exp (Warsz); 1976; 24(6):901-10. PubMed ID: 1015993
[TBL] [Abstract][Full Text] [Related]
5. Effective bisquaternary reactivators of tabun-inhibited AChE.
Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
[TBL] [Abstract][Full Text] [Related]
6. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oximes K203 and K027 based on Benchmark dose analysis of rat diaphragmal acetylcholinesterase reactivation.
Antonijevic E; Musilek K; Kuca K; Djukic-Cosic D; Andjelkovic M; Djordjevic AB; Antonijevic B
Chem Biol Interact; 2019 Aug; 308():385-391. PubMed ID: 31141677
[No Abstract] [Full Text] [Related]
8. Potential acetylcholinesterase reactivators: pyridine and alpha-oxooxime derivatives.
Daroszewski J; Serafin B; Borkowska G; Rump S
Pharmazie; 1986 Oct; 41(10):699-702. PubMed ID: 3823111
[TBL] [Abstract][Full Text] [Related]
9. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity.
Chennamaneni SR; Vobalaboina V; Garlapati A
Bioorg Med Chem Lett; 2005 Jun; 15(12):3076-80. PubMed ID: 15908205
[TBL] [Abstract][Full Text] [Related]
10. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
11. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
Thiermann H; Eyer P; Worek F; Szinicz L
Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
13. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
Lorke DE; Petroianu GA
J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
[TBL] [Abstract][Full Text] [Related]
14. Effects of oximes on mitochondrial oxidase activity.
Sakurada K; Ikegaya H; Ohta H; Fukushima H; Akutsu T; Watanabe K
Toxicol Lett; 2009 Sep; 189(2):110-4. PubMed ID: 19465093
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
[TBL] [Abstract][Full Text] [Related]
16. [Effect of mono- and bisammoniumacetonoxime salts on acetylcholinesterase and DFP].
Reiner R; Scherer A
Arzneimittelforschung; 1973 Aug; 23(8):1041-4. PubMed ID: 4801024
[No Abstract] [Full Text] [Related]
17. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. XI - Bisquaternary compounds of beta-(4-pyridyl)acraldoxime.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S
Farmaco Sci; 1977 Dec; 32(12):905-8. PubMed ID: 563345
[TBL] [Abstract][Full Text] [Related]
18. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
19. [In vitro studies of the affinity of various oximes for acetylcholinesterase from bovine erythrocytes].
Lembas-Bogaczyk J; Jacyszyn K; Rzepka Z
Folia Med Cracov; 1987; 28(1-2):193-204. PubMed ID: 3623320
[No Abstract] [Full Text] [Related]
20. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
